Coridon
Brand, Niederosterreich, Austria
About Coridon
Coridon is a privately held company headquartered in Brisbane Australia. The company was founded in 2000 for the purpose of developing DNA therapies for the prevention and treatment of viral infections such as Herpesvirus and Hepatitis C and therapeutic vaccines for the treatment of cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2010)
- Website: coridon.com
- Phone: +43 61 7 3176 5280
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/coridon-2467039 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.